INDIVIDUAL ARTICLE: Efficacy of a Prebiotic Skincare Regimen on Improving Mild Atopic Dermatitis and Severe Xerosis in Diverse Ethnically Patients

March 2024 | Volume 23 | Issue 3 | SF395747s12 | Copyright © March 2024


Published online March 1, 2024

Hawasatu Dumbuya PhDa, Katharine Podimatis MDa, Delphine Kerob MDb, Zoe Diana Draelos MDc

aLa Roche-Posay Laboratoire Dermatologique, L'Oreal USA, New York, NY
bLa Roche-Posay Laboratoire Dermatologique, L'Oreal, Levallois-Perret, France
cDermatology Consulting Services, PLLC, High Point, NC

DISCLOSURES

Dr Zoe Diana Draelos MD is a researcher and consultant for L'Oreal.

All other authors are employees of La Roche-Posay Laboratoire Dermatologique.

ACKNOWLEDGEMENTS

We thank Dr. Stephen Lynch, Mohammedali Sajun, and Komal Patel for their partnerships, plus Dr. Chesahna Kindred, Dr. Cheri N. Frey, Dr. George Han, Dr. Neal Bhatia and Dr. Katrina Abuabara for their valuable feedback on study design.

REFERENCES

  1. Silverberg JI, Nelson DB, Yosipovitch G. Addressing treatment challenges in atopic dermatitis with novel topical therapies. J Dermatolog Treat. 2016 Nov;27(6):568-576. 
  2. Silverberg JI, Gelfand JM, Margolis DJ, et al. Patient burden and quality of life in atopic dermatitis in US adults A population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121(3):340-347. 
  3. Silverberg JI. Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol. 2019;123(2):144-151 
  4. Brunner PM, Guttman-Yassky E. Racial differences in atopic dermatitis. Ann Allergy Asthma Immunol. 2019;122(5):449-455. 
  5. Kaufam BP, Guttman-Yassky E, Alexis AF. Atopic dermatitis in diverse racial and ethnic groups—Variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol. 2018;27(4):340-357 
  6. Sanfilippo E, Iyer S, Patel N, et al. Assessment of racial and ethnic differences of atopic dermatitis severity and treatment patterns in a diverse outpatient cohort in the United States: a retrospective observational study. Arch Dermatol Res. 2023;315(10):2829-2832. doi: 10.1007/ s00403-023-02696-1. 
  7. Gan C, Mahil S, Pink A, et al. Atopic dermatitis in skin of colour. Part 1: new discoveries in epidemiology and pathogenesis. Clin Exp Dermatol. 2023;48(6):609-616. 
  8. Mei-Yen Young A, Tay Y. Atopic Dermatitis: Racial and Ethnic Differences. Dermatol Clin. 2017;35(3):395-402. 
  9. Croce EA, Levy ML, Adamson AS, et al. Reframing racial and ethnic disparities in atopic dermatitis in Black and Latinx populations. J Allergy Clin Immunol. 2021;148(5):1104-1111. 
  10. Shaw TE, Currie GP, Koudelka CW, et al. Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol. 2011;131(1):67-73. 
  11. Janumpally SR, Feldman SR, Gupta AK, et al. In the United States, blacks and Asian/Pacific Islanders are more likely than whites to seek medical care for atopic dermatitis. Arch Dermatol. 2002;138(5):634-7. 
  12. Narla S, Hsu DY, Thyssen JP, et al. Predictors of hospitalization, length of stay, and costs of care among adult and pediatric inpatients with atopic dermatitis in the United States. Dermatitis. 2018;29(1):22-31. 
  13. Czarnowicki T, He H, Krueger JG, et al. Atopic dermatitis endotypes and implications for targeted therapeutics. J Allergy Clin Immunol. 2019;143(1):1-11. 
  14. Kabashima-Kubo R, Nakamura M, Sakabe J, et al. A group of atopic dermatitis without IgE elevation or barrier impairment shows a high Th1 frequency: possible immunological state of the intrinsic type. J Dermatol Sci. 2012;67(1):37-43. 
  15. Park J, Choi Y, Namkung J, et al. Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables. Br J Dermatol. 2006;155(4):778-83. 
  16. Paller AS, Kong HH, Seed P, et al. The microbiome in patients with atopic dermatitis. J Allergy Clin Immunol. 2019;143(1): 26–35. 
  17. Baldwin HE, Bhatia ND, Friedman A, et al. The role of cutaneous microbiota harmony in maintaining a functional skin barrier. J Drugs Dermatol. 2017;16(1):12-18. 
  18. Byrd AL, Belkaid Y, Segre JA. The human skin microbiome. Nat Rev Microbiol. 2018;16(3):143-155. 
  19. Bjerre RD, Holm, JB, Palleja A, et al. Skin dysbiosis in the microbiome in atopic dermatitis is site-specific and involves bacteria, fungus and virus. BMC Microbiol. 2021;21(1):256. 
  20. Simpson EL, Villarreak M, Jepson B, et al. Atopic dermatitis subjects colonized with staphylococcus aureus have a distinct phenotype and endotype. J Invest Dermatol. 2018; 138(10): 2224–2233. 
  21. Seite S, Flores GE, Henley JB, et al. Microbiome of affected and unaffected skin of patients with atopic dermatitis before and after emollient treatment. J Drugs Dermatol. 2014;13(11):1365-72. 
  22. Meylan P, Lang C, Mermoud S, et al. Skin colonization by Staphylococcus aureus precedes the clinical diagnosis of atopic dermatitis in infancy. J Invest Dermatol. 2017;137(12):2497–504. 
  23. Kennedy EA, Gallagher A, Hourihane JO, et al. Skin microbiome alterations in infants before clinical atopic dermatitis. J Invest Dermatol. 2016;136(5):S84. 
  24. Chandra J, Retuerto M, Seite S, et al. Effect of an emollient on the mycobiome of atopic dermatitis patients. J Drugs Dermatol. 2018;17(10):1039-1048. 
  25. Del Rosso JQ, Harper J, Kircik L, et al. Consensus recommendations on adjunctive topical management of atopic dermatitis. J Drugs Dermatol. 2018;17(10):1070-1076. 
  26. Alexis a, Woolery-Lloyd H, Andriessen A, et al. Insights in skin of color patients with atopic dermatitis and the role of skincare in improving outcomes. J Drugs Dermatol. 2022;21(5):462-470. 
  27. Mahe YF, Perez M, Tacheau C, et al. A new Vitreoscilla filiformis extract grown on spa water-enriched medium activates endogenous cutaneous antioxidant and antimicrobial defenses through a potential Toll-like receptor 2/protein kinase C, zeta transduction pathway. Clin Cosmet Investig Dermatol. 2013;6:191-6. 
  28. Volz T, Skabytska Y, Guenova E, el al. Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells. J Invest Dermatol. 2014;134(1):96-104.
  29. Gueniche A, Knaudt B, Schuck E, et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebo-controlled clinical study. Br J Dermatol. 2008;159(6):1357-63. 
  30. Seite S, Zelenkova H, Martin R. Clinical efficacy of emollients in atopic dermatitis patients relationship with the skin microbiota modification. Clin Cosmet Investig Dermatol. 2017;10:25-33 
  31. Zelenkova H, Kerob D, Salah S, et al. Impact of daily use of emollient 'plus' on corticosteroid consumption in patients with atopic dermatitis: An open, randomized controlled study. J Eur Acad Dermatol Venereol. 2023 Jun:37 Suppl 5:27-34. 
  32. Magnolo N, Jaenicke T, Tsianakas A, et al. Comparison of different skin care regimens in patients with moderate to severe atopic dermatitis receiving systemic treatment: A randomized controlled trial. J Eur Acad Dermatol Venereol. 2023:37 Suppl 5:18-26. 
  33. Wollenberg A, Kinberger M, Arents B, et al. European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapy. J Eur Acad Dermatol Venereol. 2022;36(9):1409-1431. 
  34. Wollenberg A, Kinberger M, Arents B, et al. European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations. J Eur Acad Dermatol Venereol. 2022;36(11):1904-1926. 
  35. Bieber T, D’Erme AM, Akdis CA, et al. Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go? J Allergy Clin Immunol. 2017;139(4S):S58-S64 
  36. Merriman JA, Mueller EA, Cahill MP, et al. Temporal and racial differences associated with atopic dermatitis staphylococcus aureus and encoded virulence factors. mSphere. 2016;1(6):e00295-16. 
  37. Hirano SA, Murray SB, Harvey VM. Reporting, representation, and subgroup analysis of race and ethnicity in published clinical trials of atopic dermatitis in the United States Between 2000 and 2009. Pediatr Dermatol. 2012 Nov-Dec;29(6):749-55. 
  38. Maudet A, Le Bec J, Flament F, et al. Analysis of images supplied by Skincam® can record the changes of some scar features that occur over time. Comparisons with the assessments of dermatologist and patients' perception. J Cosmet Dermatol. 2023;22(4):1334-1343. 
  39. Chansky PB, Mittal L, Werth VP. Dermatological evaluation in patients with skin of colour: the effect of erythema on outcome measures in atopic dermatitis. Br J Dermatol. 2017;176(4):853–854. 
  40. Wilson BN, Alexis A, Murase JE, Art of prevention: Atopic dermatitis in women and families of color-prevalence, recognition, and prevention. Int J Womens Dermatol. 2022;8(1):e014. 
  41. Zhao CY, Hao EY, Oh DD, et al. A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients. Br J Dermatol. 2017;176(4):985-992. 
  42. Schmitt J, Langan S, Deckert S, et al. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol. 2013;132(6):1337-47. 
  43. Iyer V, Raut J, Dasgupta A. Impact of pH on growth of Staphylococcus epidermidis and Staphylococcus aureus in vitro. J Med Microbiol. 2021;70(9). 
  44. Marini A, Aue N, Demessant A, et al. Increased skin pH and transepidermal water loss may serve as predictor for atopic dermatitis flares. J Eur Acad Dermatol Venereol. 2023;37(2):e252-e254. 
  45. Wan DC, Wong VW, Longaker MT, et al. Moisturizing different racial skin types. J Clin Aesthet Dermatol. 2014;7(6):25-32. 
  46. Young MM, Franken A, du Plessis JL. Transepidermal water loss, stratum corneum hydration, and skin surface pH of female African and Caucasian nursing students. Skin Res Technol. 2019;25(1):88-95. 
  47. Berardesca E, Pirot F, Singh M, et al. Differences in stratum corneum pH gradient when comparing white Caucasian and black African-American skin. Br J Dermatol. 1998;139(5):855-7. 
  48. Reed JT, Ghadially R, Elias PM. Skin type, but neither race nor gender, influence epidermal permeability barrier function. Arch Dermatol. 1995;131(10):1134-8. 
  49. Muizzuddin N, Hellemans L, Van Overloop L. Structural and functional differences in barrier properties of African American, Caucasian and East Asian skin. J Dermatol Sci. 2010;59(2):123-8. 
  50. Silverberg JI, Shi VY, Alexis A, et al. Racial and ethnic differences in sociodemographic, clinical, and treatment characteristics among patients with atopic dermatitis in the United States and Canada: real-world data from the CorEvitas atopic dermatitis registry. Dermatol Ther (Heidelb). 2023;13(9):2045-2061. 
  51. Shaw FM, Luk KMH, Chen KH, et al. Racial disparities in the impact of chronic pruritus: A cross-sectional study on quality of life and resource utilization in United States veterans. J Am Acad Dermatol. 2017;77(1):63-69. 
  52. Ingrasci G, El-Kashlan N, Alexis A, et al. Chronic itch in African Americans: an unmet need. Arch Dermatol Res. 2022;314(5):405-415. 
  53. Alexis AF, Woolery-Lloyd H, Williamas K, et al. Racial/Ethnic variations in skin barrier: implications for skin care recommendations in skin of color. J Drugs Dermatol. 2021;20(9):932-938.
  54. Crudele J, Kim E, Murray K, et al. The importance of understanding consumer preferences for dermatologist recommended skin cleansing and care products. J Drugs Dermatol. 2019;18(1s):s75-79

AUTHOR CORRESPONDENCE

Hawasatu Dumbuya PhD hawasatu.dumbuya@loreal.com
Close Menu